Technical Articles

This technical platform offers precise evaluation services for the binding affinity between antigenic peptides and HLA-I molecules, enabling efficient screening of antigenic epitopes with HLA-I-restricted presentation potential. The technological system has been maturely applied in the following domains: 1) Development of immunotherapy targets for tumors (e.g., tumor neoantigen screening), 2) Personalized tumor vaccine preparation (including custom synthesis of MHC-I multimers), and 3) Vaccine research for infectious diseases (e.g., monitoring of virus-specific T cell immune responses).